These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7640267)
1. Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Iwai A; Yoshimoto M; Masliah E; Saitoh T Biochemistry; 1995 Aug; 34(32):10139-45. PubMed ID: 7640267 [TBL] [Abstract][Full Text] [Related]
2. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils. El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705 [TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Uéda K; Fukushima H; Masliah E; Xia Y; Iwai A; Yoshimoto M; Otero DA; Kondo J; Ihara Y; Saitoh T Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11282-6. PubMed ID: 8248242 [TBL] [Abstract][Full Text] [Related]
4. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Weinreb PH; Zhen W; Poon AW; Conway KA; Lansbury PT Biochemistry; 1996 Oct; 35(43):13709-15. PubMed ID: 8901511 [TBL] [Abstract][Full Text] [Related]
5. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Yoshimoto M; Iwai A; Kang D; Otero DA; Xia Y; Saitoh T Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9141-5. PubMed ID: 7568089 [TBL] [Abstract][Full Text] [Related]
6. Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid. Paik SR; Lee JH; Kim DH; Chang CS; Kim J Arch Biochem Biophys; 1997 Aug; 344(2):325-34. PubMed ID: 9264546 [TBL] [Abstract][Full Text] [Related]
7. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Masliah E; Iwai A; Mallory M; Uéda K; Saitoh T Am J Pathol; 1996 Jan; 148(1):201-10. PubMed ID: 8546207 [TBL] [Abstract][Full Text] [Related]
8. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400 [TBL] [Abstract][Full Text] [Related]
9. Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging. Joachim CL; Duffy LK; Morris JH; Selkoe DJ Brain Res; 1988 Nov; 474(1):100-11. PubMed ID: 3214703 [TBL] [Abstract][Full Text] [Related]
10. An antiserum against amyloid beta-protein precursor detects a unique peptide in Alzheimer brain. Cole G; Masliah E; Huynh TV; DeTeresa R; Terry RD; Okuda C; Saitoh T Neurosci Lett; 1989 May; 100(1-3):340-6. PubMed ID: 2503790 [TBL] [Abstract][Full Text] [Related]
11. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Han H; Weinreb PH; Lansbury PT Chem Biol; 1995 Mar; 2(3):163-9. PubMed ID: 9383418 [TBL] [Abstract][Full Text] [Related]
12. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Iwai A; Masliah E; Yoshimoto M; Ge N; Flanagan L; de Silva HA; Kittel A; Saitoh T Neuron; 1995 Feb; 14(2):467-75. PubMed ID: 7857654 [TBL] [Abstract][Full Text] [Related]
13. The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis. Soto C; Castaño EM Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):701-7. PubMed ID: 8670088 [TBL] [Abstract][Full Text] [Related]
14. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein. Coria F; Castaño EM; Frangione B Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021 [TBL] [Abstract][Full Text] [Related]
15. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Castaño EM; Ghiso J; Prelli F; Gorevic PD; Migheli A; Frangione B Biochem Biophys Res Commun; 1986 Dec; 141(2):782-9. PubMed ID: 3541938 [TBL] [Abstract][Full Text] [Related]
16. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195 [TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5). Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128 [TBL] [Abstract][Full Text] [Related]
18. Amyloid beta protein and the basis for Alzheimer's disease. Glenner GG Prog Clin Biol Res; 1989; 317():857-68. PubMed ID: 2690126 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis. Alizadeh-Khiavi K; Normand J; Chronopoulos S; Ali-Khan Z Acta Neuropathol; 1991; 81(3):280-6. PubMed ID: 1647643 [TBL] [Abstract][Full Text] [Related]
20. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. Styren SD; Hamilton RL; Styren GC; Klunk WE J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]